Brad Nawa

Director-Commercial at Sengenics
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Fortville, Indiana, United States, IN

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology
    • 1 - 100 Employee
    • Director-Commercial
      • Jun 2022 - Present

      Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, therapeutic response prediction and development of companion diagnostics. Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, therapeutic response prediction and development of companion diagnostics.

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Director Business Development & Commercialization
      • Sep 2020 - Jun 2022

      Epic Sciences is a company that was founded to develop new, high-definition diagnostic tests focused on the circulating tumor cell and blood based tumor microenvironment to provide clinically relevant information about how a patient’s cancer changes over time, which will allow for improved therapy selection and early drug resistance detection in the liquid biopsy Epic Sciences is a company that was founded to develop new, high-definition diagnostic tests focused on the circulating tumor cell and blood based tumor microenvironment to provide clinically relevant information about how a patient’s cancer changes over time, which will allow for improved therapy selection and early drug resistance detection in the liquid biopsy

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Director Business Development Translational Biomarkers and Companion Diagnostics
      • Jun 2018 - Sep 2020

      Labcorp Drug Development is a contract research organization headquartered in Burlington, North Carolina, providing nonclinical, preclinical, clinical and commercialization services to pharmaceutical and biotechnology industries. Labcorp Drug Development is a contract research organization headquartered in Burlington, North Carolina, providing nonclinical, preclinical, clinical and commercialization services to pharmaceutical and biotechnology industries.

    • Sweden
    • Biotechnology Research
    • 400 - 500 Employee
    • Business Development Manager
      • May 2016 - Jun 2018

      OLINK Proteomics provide innovative products & services for targeted human protein biomarker discovery. We provide rapid, high-throughput analysis with exceptional data quality and minimal consumption of precious samples. Our groundbreaking Proseek® Multiplex solution for precision proteomics brings new insights into disease processes, improve disease detection, and contribute to a better understanding of biology. We would enjoy the opportunity to share our vision with you for the developing role of Olink Proteomics in the future of precision diagnostics and the realization of precision medicine. Show less

    • Biotechnology Research
    • 500 - 600 Employee
    • Business Development Manager
      • Jan 2009 - Mar 2016

      MSD has developed proprietary technology for the measurement of molecules in biological samples. Our technology enables researchers to profile biomarkers such as cytokines and intracellular signaling proteins, which has a direct impact on drug discovery and improving human health. MSD’s combination of electrochemiluminescence and MULTI‑ARRAY technology provides unsurpassed sensitivity and multiplex functionality making it an exceptional detection system. MSD has developed proprietary technology for the measurement of molecules in biological samples. Our technology enables researchers to profile biomarkers such as cytokines and intracellular signaling proteins, which has a direct impact on drug discovery and improving human health. MSD’s combination of electrochemiluminescence and MULTI‑ARRAY technology provides unsurpassed sensitivity and multiplex functionality making it an exceptional detection system.

    • United States
    • Medical Equipment Manufacturing
    • 700 & Above Employee
    • Pharmaceutical Key Account Manager
      • Aug 2000 - Jan 2009

Education

  • Indiana University Bloomington
    BA, Chemistry Math
  • Indiana University–Purdue University Indianapolis
    MS, Biology
  • Indiana University - Kelley School of Business
    MBA

Community

You need to have a working account to view this content. Click here to join now